This project brief describes PATH’s contributions to developing public-private mix (PPM) approaches to TB control in India. With support from the United States Agency for International Development, PATH supported a PPM pilot project in Andhra Pradesh that aimed to train private chemists in identifying presumed TB cases and referring them to government diagnosis centers, promoting community awareness of TB prevention, and reducing the sale of TB drugs to persons without a prescription. This project provided valuable lessons and insights into applying PPM strategies to future TB control projects in India and elsewhere.

Publication date: May 2014

Region: Asia

Part of series: Tuberculosis activities in India

Part of the Technology Updates series, this fact sheet describes PATH's work to develop a rectally administered magnesium sulfate (MgSO4) formulation that could simplify delivery and improve access to MgSO4 treatment in low-resource settings.

Publication date: May 2014

Region: Global

Part of series: Technology Updates

This fact sheet provides an overview of rotavirus disease and vaccines in Eritrea. It includes information about the tremendous burden of rotavirus diarrhea in Eritrean children, rotavirus diarrhea treatment and prevention strategies, and the effectiveness of rotavirus vaccines.

Publication date: May 2014

Region: Global

Part of series: Rotavirus disease and vaccines fact sheets

This fact sheet provides an overview of rotavirus disease and vaccines in Niger. It includes information about the tremendous burden of rotavirus diarrhea in Nigerien children, rotavirus diarrhea treatment and prevention strategies, and the effectiveness of rotavirus vaccines.

Publication date: May 2014

Region: Africa

Part of series: Rotavirus disease and vaccines fact sheets

Severe preeclampsia and eclampsia (PE/E) are among the leading causes of maternal death and disability worldwide. Magnesium sulfate is the treatment recommended by the World Health Organization, but it remains underutilized due to difficult administration. PATH designed a mobile application for dosing and dilution of magnesium sulfate to address the challenges of correctly calculating magnesium sulfate dosage given multiple concentrations and a complex dosing regimen.

Publication date: May 2014

Region: Global

This project brief showcases PATH's contributions to tuberculosis (TB) and HIV service integration in Tanzania. This work was made possible through generous funding from the United States Agency for International Development. For a related brief on pediatric TB in Tanzania, see Finding and Treating Tuberculosis in Children.

Publication date: May 2014

Region: Africa

This annotated target product profile (TPP) describes the desired characteristics of an HIV self-test and is a result of a review of currently available literature, interviews with key informants/stakeholders, laboratory-generated data on the performance of rapid tests, and early usability studies in Kenya, Malawi, and South Africa. The purpose of the TPP is to provide a common foundation for the development of HIV self-tests that contains sufficient detail to allow device developers and key stakeholders to understand the characteristics a test must have to be successful.

Author: Peck RB, Lim JM, Wellhausen JD, Lee AM, Valdez MM

Publication date: May 2014

Region: Global

This fact sheet provides an overview of the work of PATH's Malaria Control and Elimination Partnership in Africa (MACEPA) to develop and document approaches for reducing malaria illnesses and deaths, with the long-term goal of malaria elimination.

Publication date: April 2014

Region: Africa

With funding from the Canadian International Development Agency, PATH is working to address the information gap on how to best tailor and scale up proven HIV prevention strategies among at-risk populations through cost-effective interventions in India, Senegal, Uganda, Zambia, and Zimbabwe.

Publication date: April 2014

Region: Global

Cervical Cancer Action is a global partnership chaired by PATH and aimed at reducing cervical cancer in high-burden, low-income countries. Seven years after its founding and eight years after human papillomavirus vaccines first became available, Cervical Cancer Action offers this snapshot of its accomplishments to date and its vision of the work ahead.

Publication date: April 2014

Region: Global

This brief provides policy recommendations to help Tanzania reduce the impacts of pneumonia and diarrhea and ensure all children have the chance to lead healthy lives.

Publication date: April 2014

Region: Africa

Part of the Technology Updates series, this fact sheet describes PATH and our partners’ work to validate a new web-based cold chain equipment inventory (CCEI) tool, which is a module of the DHIS2 open-source software platform. This tool will provide opportunities for countries to integrate CCEI data into their national health management information systems.

Publication date: April 2014

Region: Global

Part of series: Technology Updates

This fact sheet describes PATH's work to eliminate malaria, including expanding the use of lifesaving tools, identifying and developing better diagnostics and drugs, devising new strategies for malaria control, and accelerating the development of malaria vaccines.

Publication date: April 2014

Region: Global

Part of series: Areas of focus fact sheets

Part of the Technology Updates series, this fact sheet describes PATH's work on low-cost respiratory support devices for newborns.

Publication date: April 2014

Region: Global

Part of series: Technology Updates

Part of the Technology Updates series, this fact sheet describes PATH's approach to technologies for oral delivery of vaccines.

Publication date: April 2014

Region: Global

Part of series: Technology Updates

This fact sheet provides an overview of PATH’s work in noncommunicable diseases (NCDs). Our goal is to reduce preventable morbidity and mortality by using innovation and technology to increase access to prevention and care for NCDs in low-resource settings.

Publication date: April 2014

Region: Global

Part of the Technology Updates series, this fact sheet describes PATH's and our partners' work on a new approach to health education in resource-poor settings. Projecting Health, also known as Digital Public Health, uses customized educational videos developed and produced by local communities to effectively improve health knowledge and behaviors.

Publication date: April 2014

Region: Global

Part of series: Technology Updates

Part of the Technology Updates series, this fact sheet describes PATH’s work with diagnostic developers and stakeholders from around the world to develop a rapid, point-of-care diagnostic test for glucose-6 phosphate dehydrogenase (G6PD) deficiency. A reliable test for G6PD at the point of care is essential to malaria elimination strategies.

Publication date: April 2014

Region: Global

Part of series: Technology Updates

This fact sheet provides an overview of rotavirus disease and vaccines in Madagascar. It includes information about the tremendous burden of rotavirus diarrhea in Malagasy children, rotavirus diarrhea treatment and prevention strategies, and the effectiveness of rotavirus vaccines. It also lists countries that have introduced rotavirus vaccines into their national immunization programs.

Publication date: April 2014

Region: Africa

Part of series: Rotavirus disease and vaccines fact sheets

Artemisinin-based combination therapy is considered the gold standard treatment for malaria, but global demand has often outpaced production, and pricing has been volatile. With funding from the Bill & Melinda Gates Foundation, PATH and our partners set out to develop a new pharmaceutical manufacturing process to produce commercial volumes of high-quality, nonseasonal, and affordable artemisinin to supplement the plant-based supply. This poster, presented at the Bay Area World Malaria Day Symposium on April 25, 2014, presents key facts on malaria, the market for artemisinin, partner roles, and commercial production.

Publication date: April 2014

Region: Global